XML 61 R43.htm IDEA: XBRL DOCUMENT v3.25.0.1
Collaboration and License Agreements - Gilead Sciences, Inc. (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2024
USD ($)
$ / shares
shares
Apr. 30, 2024
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
item
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
Agreements          
Revenue       $ 6,344  
Revenue from Contract with Customer, Product and Service       us-gaap:LicenseMember us-gaap:LicenseMember
Deferred revenue, current portion $ 13,518     $ 13,518  
License and Stock Purchase Agreement | Gilead Sciences, Inc.          
Agreements          
Maximum additional contingent payments receivable, Transition fee     $ 75,000 $ 75,000  
Value of shares counterparty agreed to purchase     $ 25,000    
Number of additional private placements | item     3    
Maximum beneficial ownership (as a percent)   19.90%      
Common stock issued and sold (in shares) | shares 1,759,978 485,250 6,860,223    
Purchase price (in dollars per share) | $ / shares $ 1.04 $ 0.76 $ 1.97 $ 1.04  
Gross proceeds from private placement $ 8,200 $ 3,300 $ 13,500 $ 25,000  
Upfront payment       55,000  
Upfront payment, cash       30,000  
Maximum additional contingent payments receivable       592,500  
Maximum additional contingent payments receivable, Milestones       517,500  
Maximum additional contingent payments receivable, Near-term development milestones       17,500  
Fair market value of common stock issued (in dollars)     4,400    
Premium of common stock issued (in dollars)     9,100    
Transaction price     39,100    
Transaction price, Cash payment     30,000    
Transaction price, Premium on sale of stock     $ 9,100    
Revenue       $ 6,300  
Revenue from Contract with Customer, Product and Service       us-gaap:LicenseMember  
Deferred revenue 32,780     $ 32,780
Current liability $ 13,500     $ 13,500  
License and Stock Purchase Agreement | Gilead Sciences, Inc. | Prefunded warrants          
Agreements          
Warrants issued (in shares) | shares 6,092,816 3,882,450      
Purchase price, warrant (in dollars per share) | $ / shares $ 1.0399 $ 0.7599   $ 1.0399  
Exercise price, warrants (in dollars per share) | $ / shares $ 0.0001 $ 0.0001   $ 0.0001